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matter injury
Author: 1,2) Thomi G., 1) Joerger-Messerli M.S., 1) Haesler V., 1) Schoeberlein A., 1) Surbek D.
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Objective: Survivors of preterm birth are at risk to suffer from white matter injury (WMI) lea-
ding to subsequent neurodevelopmental deficits. Preterm-specific WMI is characterized by 
a disruption of normal developmental myelination of the brain. In animal models of WMI, 
Wharton’s jelly mesenchymal stem/stromal cells (WJ-MSC) derived from umbilical cords res-
tore normal myelination, in part through the release of cell-derived extracellular vesicles like 
exosomes. We aimed to test the therapeutic potential of WJ-MSC-derived exosomes in an 
animal model of preterm WMI.
Study Design: We isolated exosomes from WJ-MSC culture supernatants using serial centri-
fugation. Consistent with the etiology of WMI in preterm infants, we introduced brain injury 
in 3-day old rat pups with lipopolysaccharide i.p. and unilateral carotid artery cauterization 
followed by hypoxia (8% O2). As a treatment, animals received an intranasal administration 
of infrared-labeled exosomes which were traced inside the bodies of the animals. In a short-
term experiment, we analyzed cortical apoptosis and myelination using TUNEL-assay, real-
time RT-PCR and Western blot. In a long-time experiment, we tracked the survival and lear-
ning capacity of the animals using the Morris water maze assay. 
Results: Intranasally administered exosomes rapidly translocated to the brain and arrived 
within 30 min after administration. Treated animals exhibited reduced cortical apoptosis 
and diminished hypomyelination 9 days after brain injury as the exosomes rescued the loss 
of myelin basic protein (p<0.05). Exosome treatment doubled the animal’s overall survival 
rate (p<0.01) and improved their learning capacity (p<0.05) 1 month after WMI.
Conclusion: Treatment with WJ-MSC-derived exosomes improves survival, partially restores 
normal developmental myelination and alleviates associated neurodevelopmental deficits. 
Intranasal administration of WJ-MSC-derived exosomes represents a minimally-invasive and 
effective treatment for WMI.
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